EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis

Acta Neurologica Scandinavica

Volumn 124, Issue 6, 2011, Pages 424-428

  Ilzecka, J ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Amyotrophic lateral sclerosis; Extracellular matrix metalloproteinase inducer; Neurodegeneration; Pathophysiology; Serum

Indexed keywords

CD147 ANTIGEN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HUMAN; MALE; NOTE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIGENS, CD147; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 80054934044     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01519.x     Document Type: Note

References (30)

1. Renaud S, Leppert D. Matrix metalloproteinases in neuromuscular disease. Muscle Nerve 2007;36:1-13.
2. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 2002;39:279-91.
3. Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009;8:205-16.
4. Lim GP, Backstrom JR, Cullen MJ, Miller CA, Atkinson RD, Tokes ZA. Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J Neurochem 1996;67:251-9.
5. Fang L, Huber-Abel F, Teuchert M et al. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS). J Neurol Sci 2009;285:62-6.
6. Demestre M, Parkin-Smith G, Petzold A, Pullen AH. The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis. J Neuroimmunol 2005;159:146-54.
7. Sokolowska B, Jóźwik A, Niebrój-Dobosz I, Janik P, Kwieciński H. Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods. J Physiol Pharmacol 2009;60(Suppl. 5):117-20.
8. Beuche W, Yushchenko M, Mader M, Maliszewska M, Felgenhauer K, Weber F. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuroreport 2000;11:3419-22.
9. Lorenzl S, Albers DS, Lewitt PA et al. Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. J Neurol Sci 2003;207:71-6.
10. Niebrój-Dobosz I, Janik P, Sokolowska B, Kwieciński H. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Neurol 2010;17:226-31.
11. Kiaei M, Kipiani K, Calingasan NY et al. Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis. Exp Neurol 2007;205:74-81.
12. Fang L, Teuchert M, Huber-Abel F et al. MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS. J Neurol Sci 2010;294:51-6.
13. Caydroy S, Polette M, Nawrocki-Raby B et al. EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clin Exp Metastasis 2002;19:697-702.
14. Biswas C, Zhang Y, Decastro R et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995;55:434-9.
15. Naruhashi K, Kadomatsu K, Igakura T et al. Abnormalities of sensory and memory functions in mice lacking Bsg gene. Biochem Biophys Res Commun 1997;236:733-7.
16. Igakura T, Kadomatsu K, Taguchi O et al. Roles of besigin, a member of the immunoglobulin superfamily, in behavior as to an irritating odor, lymphocyte response and blood-brain barrier. Biochem Biophys Res Commun 1996;224:33-6.
17. Muramatsu T, Miyauchi T. Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histol Histopathol 2003;18:981-7.
18. Nabeshima K, Iwasaki H, Koga K et al. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 2006;56:359-67.
19. Agrawal SM, Yong VW. The many faces of EMMPRIN - Roles in neuroinflammation. Biochim Biophys Acta 2011;1812:213-9.
20. Brooks BR. El Escorial Word Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(Suppl.):96-107.
21. Gordon PH, Miller RG, Moore DH. ALSFRS-R. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:90-3.
22. Burggraf T, Liebetrau M, Martens HK et al. Matrix metalloproteinase induction by EMMPRIN in experimental focal cerebral ischemia. Eur J Neurosci 2005;22:273-7.
23. Zhu W, Khachi S, Hao Q et al. Upregulation of EMMPRIN after permanent focal cerebral ischemia. Neurochem Int 2008;52:1086-91.
24. Nahalkova J, Volkmann I, Aoki M et al. CD147, a gamma-secretase associated protein is upregulated in Alzheimer's disease brain and its cellular trafficking is affected by presenilin-2. Neurochem Int 2010;56:67-76.
25. Zhou S, Zhou H, Walian PJ, Jap BK. CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta - peptide production. Proc Natl Acad Sci USA 2005;102:7499-504.
26. Agrawal SM, Silva C, Tourtellotte WW, Yong VW. EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci 2011;31:669-77.
27. Keizman D, Rogowski O, Berliner S et al. Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis. Acta Neurol Scand 2009;119:383-9.
28. Ono S. Skin changes in amyotrophic lateral sclerosis. Brain Nerve 2007;59:1099-107.
29. Ono S, Imai T, Takahashi K, Jinnai K, Shimizu N, Nagao K. Increased type III procollagen in serum and skin of patients with amyotrophic lateral sclerosis. Acta Neurol Scand 1999;100:377-84.
30. Suzuki M, Mikami H, Watanabe T et al. Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis. Acta Neurol Scand 2010;122:367-72.